Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013–2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)

<i>Background</i><b>:</b> Bacterial antibiotic resistance changes over time depending on multiple factors; therefore, it is essential to monitor the susceptibility trends to reduce the resistance impact on the effectiveness of various treatments. <i>Objective</i><b>:</b> To conduct a time-trend anal...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Luis Bujanda, Olga P. Nyssen, Dino Vaira, Ilaria M. Saracino, Giulia Fiorini, Frode Lerang, Sotirios Georgopoulos, Bojan Tepes, Frederic Heluwaert, Antonio Gasbarrini, Theodore Rokkas, Dmitry Bordin, Sinead Smith, Vincent Lamy, María Caldas, Elena Resina, Raquel Muñoz, Ángel Cosme, Ignasi Puig, Francis Megraud, Colm O’Morain, Javier P. Gisbert, on behalf of the Hp-EuReg Investigators
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2021-09-01
Ráidu:	Antibiotics
Fáttát:	<i>Helicobacter pylori</i> amoxicillin clarithromycin metronidazole levofloxacin tetracycline
Liŋkkat:	https://www.mdpi.com/2079-6382/10/9/1058
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!